osim FA pdf

CORPORATEGOVERNANCE
Our Directors and management are committed to high standards of corporate governance in order to
protect the interests of our employees, customers and Shareholders, and follow closely the best practices
outlined in the Best Practices Guide issued by the Singapore Exchange Securities Trading Limited (SGX-ST):
Board of Directors
Our Board of Directors, comprising seven members, is made up of 3 executive Directors and 4 non-
executive Directors. The Chairman / Chief Executive Officer Dr Ron Sim Chye Hock, the Chief Operating
Officer Mr Teo Chay Lee and the Regional General Manager Mr Leow Lian Soon are the executive directors.
The non-executive directors are Ms Teo Sway Heong, Mr Khor Peng Soon, Mr Michael Kan Yuet Yun and
Mr Ong Kian Min.
The Board will meet periodically throughout the year. To assist the Board of Directors in discharging its
responsibilities, we have the following Committees:-
The Executive Committee
The Executive Committee comprises the 3 executive Directors, Dr Ron Sim Chye Hock, Mr Teo Chay Lee,
Mr Leow Lian Soon and the Chief Financial Officer Mr Lee Hwai Kiat. The Committee will assist the Board
to strengthen our management culture and direct the Group towards fulfilling our vision of being a global
brand name in home health care products. The Committee will also assist the Board to allocate resources
of the Group after considering the risks and returns associated with our operations, including business and
financial risks;
Audit Committee
The Audit Committee comprises 2 independent Directors, Mr Michael Kan Yuet Yun, Mr Ong Kian Min and
1 executive Director, Mr Teo Chay Lee. Mr Michael Kan Yuet Yun is the Chairman of the Audit Committee.
The main objective of the Committee is to assist the Board of Directors in fulfilling the fiduciary responsibilities
of the Company and each of its subsidiaries. The Committee will:
(i) oversee and appraise the quality of the audit of the Company's internal audit function and of its external
auditors;
(ii) serve as an independent and objective party to review the financial information presented by the
Management to Shareholders, regulators and general public; and
(iii) examine the adequacy of the Company's administrative and operating controls as well as internal
accounting controls and evaluate adherence.
Annual Report 2000
29